Metalloprotease disintegrins are a family of membrane-anchored glycoprotein
s that are known to function in fertilization, myoblast fusion, neurogenesi
s, and ectodomain shedding of tumor necrosis factor (TNF)-alpha. Here we re
port the analysis of the intracellular maturation and catalytic activity of
the widely expressed metalloprotease disintegrin MDC9, Our results suggest
that the pro-domain of MDC9 is removed by a furin-type pro-protein convert
ase in the secretory pathway before the protein emerges on the cell surface
. The soluble metalloprotease domain of MDC9 cleaves the insulin B-chain, a
generic protease substrate, providing the first evidence that MDC9 is cata
lytically active. Soluble MDC9 appears to have distinct specificities for c
leaving candidate substrate peptides compared with the TNF-cu convertase (T
ACE/ADAM17). The catalytic activity of MDC9 can be inhibited by hydroxamic
acid-type metalloprotease inhibitors in the low nanomolar range, in one cas
e with up to 50-fold selectivity for MDC9 versus TACE, Peptides mimicking t
he predicted cysteine-switch region of MDC9 or TACE inhibit both enzymes in
the low micromolar range, providing experimental evidence for regulation o
f metalloprotease disintegrins via a cysteine-switch mechanism. Finally, MD
C9 is shown to become phosphorylated when cells are treated with the phorbo
l ester phorbol la-myristate 13-acetate, a known inducer of protein ectodom
ain shedding. This work implies that removal of the inhibitory pro-domain o
f MDC9 by a fur-in-type pro-protein convertase in the secretory pathway is
a prerequisite for protease activity, After pro-domain removal, additional
steps, such as protein kinase C-dependent phosphorylation, may be involved
in regulating the catalytic activity of MDC9, which is likely to target dif
ferent substrates than the related TNF-alpha-convertase.